Leverkusen, Germany

Jurgen-Dietrich Meier

This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1976-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jurgen-Dietrich Meier. Retrieved from https://idiyas.com/inventor/jurgen-dietrich-meier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Cologne, DE (1976)
  • Leverkusen, DE (1996)

Company Filing History:


Years Active: 1976-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jurgen-Dietrich Meier: Innovator in Pharmaceutical Chemistry

Introduction

Jurgen-Dietrich Meier is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on innovative processes and compositions that address various medical challenges.

Latest Patents

Among his latest patents, Jurgen-Dietrich Meier has developed a process for the preparation of 2-aryl-ethane-sulphonic acids. This includes the creation of pharmaceutical compositions useful for treating tick infestations. Additionally, he has worked on 2-Phenyliminopyrrolidines, which are crucial for various therapeutic applications.

Career Highlights

Jurgen-Dietrich Meier is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His role at Bayer has allowed him to contribute to groundbreaking research and development in the industry.

Collaborations

Throughout his career, Jurgen-Dietrich Meier has collaborated with esteemed colleagues, including Christian Munster and Volker Kass. These partnerships have fostered innovation and enhanced the impact of their collective work in pharmaceutical advancements.

Conclusion

Jurgen-Dietrich Meier's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing health challenges. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…